Skip to main content
. Author manuscript; available in PMC: 2015 Dec 18.
Published in final edited form as: Gut. 2015 Jan 30;64(11):1783–1789. doi: 10.1136/gutjnl-2014-308653

Table 3.

Estimates from multiple linear regression models for age, adjusting for patient race, sex, tumour location and grade among patients with stage I or II disease (first column) and stage I, II or III disease (second column)

Stages I, II Stages I, II, III
Adjusted mean
age (years), T1
60.03 (58.56 to 61.5) 60.68 (59.3 to 62.06)
Age difference
(years): T2 vs T1
−0.01 (−1.06 to 1.05), p=0.99 0.03 (−1.03 to 1.1), p=0.95
Age difference
(years): T3 vs T1
0.95 (0.01 to 1.89), p=0.05 1.06 (0.11 to 2), p=0.03
Age difference
(years): T4 vs T1
N.A. 1.19 (0.11 to 2.27), p=0.03

Separate models were estimated for varying subgroups of patient stage of disease. Values given are mean differences in ages by T stage, with 95% CIs.